E-DRUG: WHO Technical Briefing Seminar: QA and Safety of Medicines
------------------------------------------------------------------
Dear Colleague,
The Quality Assurance and Safety: Medicines team (in the Department of
Medicines Policy and Standards), WHO is organizing a Technical Briefing
Seminar by the title:
Quality Assurance and Safety of Medicines: Promoting Global Collaboration
Venue: WHO Headquarters, Geneva, Salle D
Dates: 26-30 November 2007
The objective of the Seminar is to advance collaboration between WHO and
other stakeholders from governmental and non-governmental organizations
engaged in promoting the quality and safety of medicines in the global
community.
The programme has been developed to increase awareness and knowledge of
quality assurance and safety of medicines, blood products and related
biologicals with a special focus on WHO standard-setting processes.
Presentations, briefing and discussion topics will include :
* WHO development of guidelines, pharmacopoeial monographs and
information resources
* collaborative approaches underpinning classification systems
(International nonproprietary names, Anatomical Therapeutic Chemical
(ATC) Classification
* quality assurance of medicines, blood products and related
biologicals
* WHO prequalification project activities
* WHO global pharmacovigilance programme
* WHO input to international control of narcotic and psychotropic
substances
Audience
The technical briefing will be of interest to technical officers, WHO
Representatives, regional advisers and country office staff of WHO and
other UN agencies, national and regional drug regulators, and government
and non-government officials working in related areas.
Specific Objectives
By attending this briefing, participants will understand:
1. The methodologies, technical tools and algorithms used to develop WHO
guidelines;
2. The roles and functions of the Quality Assurance and Safety:
Medicines (QSM), and Quality Assurance and Safety: Blood Products and
Related Biologicals (QSD) teams and how they collaborate with other WHO
departments and Member States in promoting global standards of quality
and safety of human medicines;
3. The activities of the WHO Regional Offices and WHO Collaborating
Centres;
4. How QSM / QSD activities help meet the goals and strategic objectives
of the WHO Essential Medicines Programme.
Seminar design
This will be in the form of an interactive seminar with presentations on
individual topics followed by working group exercises on specific tools
and techniques (e.g. databases, adverse drug reaction reporting forms,
case studies etc). Technical officers from WHO and relevant
Collaborating Centres, senior consultants and WHO experts will lead and
facilitate the programme.
The full programme as well as application details are available at :
http://www.who.int/medicines/areas/quality_safety/qsm_tbs/en/index.html
[Programme is at: http://www.who.int/medicines/areas/quality_safety/DraftProgramme.pdf
Attendance is limited to 35 places. Participation is free of charge.
However, each participant is responsible for own travel and
accommodation costs.
The closing date for submission of applications is 15 September 2007.
Completed application forms should be sent to:
Mrs Maria Cuadrillero
Quality Assurance and Safety: Medicines
World Health Organization
Geneva 1211
Switzerland
Fax: 00 41 22 791 4730
E-mail: cuadrillerom@who.int
With best regards,
Shanthi Pal
Technical Officer
Quality Assurance and Safety: Medicines
WHO
1211 Geneva 27
Switzerland
Tel: +41-22-7911318
Fax: +41-22-7914730
pals@who.int